Correlation Between Chimerix and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Chimerix and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chimerix and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chimerix and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Chimerix and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chimerix with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chimerix and Tarsus Pharmaceuticals.
Diversification Opportunities for Chimerix and Tarsus Pharmaceuticals
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Chimerix and Tarsus is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Chimerix and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Chimerix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chimerix are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Chimerix i.e., Chimerix and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Chimerix and Tarsus Pharmaceuticals
Given the investment horizon of 90 days Chimerix is expected to under-perform the Tarsus Pharmaceuticals. In addition to that, Chimerix is 1.25 times more volatile than Tarsus Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.25 per unit of volatility. If you would invest 4,387 in Tarsus Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 697.00 from holding Tarsus Pharmaceuticals or generate 15.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Chimerix vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Chimerix |
| Tarsus Pharmaceuticals |
Chimerix and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chimerix and Tarsus Pharmaceuticals
The main advantage of trading using opposite Chimerix and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chimerix position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Chimerix vs. Assembly Biosciences | Chimerix vs. Spero Therapeutics | Chimerix vs. Achilles Therapeutics PLC | Chimerix vs. Instil Bio |
| Tarsus Pharmaceuticals vs. Bright Minds Biosciences | Tarsus Pharmaceuticals vs. HP Inc | Tarsus Pharmaceuticals vs. Intel | Tarsus Pharmaceuticals vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |